RRPV Solicitation Summary: Rapid Antigen Production for Immunoassay Diagnostics (RAPID)

Location:	Federal
Posted:	Apr 15, 2026
Due:	May 13, 2026
Agency:	HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Type of Government:	Federal
Category:	A - Research and development
Solicitation No:	RRPV-RPP-26-10-RAPID
Publication URL:	To access bid details, please log in.

Active

Contract Opportunity

Notice ID

RRPV-RPP-26-10-RAPID

Related Notice

Department/Ind. Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier

OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Office

BARDA - ASPR / DAAPPO / BARDA DCMA

General Information

Contract Opportunity Type: Special Notice (Original)
Original Published Date: Apr 15, 2026 03:00 pm EDT
Original Response Date: May 13, 2026 01:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 28, 2026
Initiative:
- None

Classification

Original Set Aside: No Set aside used
Product Service Code: AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Place of Performance:

Description

This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) entitiled "Rapid Antigen Production for Immunoassay Diagnostics (RAPID)".

Through the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP, BARDA seeks to support advanced research and development of rapid antibody and other protein-based molecular recognition reagent generation platforms to enable timely production of immunoassay-ready reagents for diagnostic use. The objective is to establish flexible, end-to-end systems capable of generating high-performance binders against known and emerging biological threats, with the goal of significantly compressing development timelines from pathogen sequence to assay-ready reagents—ideally within weeks.

A Proposer’s Conference and Teaming Connect for the Rapid Antibody Production for Immunoassay Diagnostics (RAPID) RPP will take place virtually on Monday, April 27, 2026 from 11am-12pm EST.

The full RPP, how to register for the Conference, and information on joining the consortium can be accessed through the RRPV website - www.rrpv.org.

Attachments/Links

Contact Information

Contracting Office Address

O’NEILL HOUSE OFFICE BUILDING
WASHINGTON , DC 20515
USA

Primary Point of Contact

Rebecca Harmon
rebecca.harmon@ati.org

Secondary Point of Contact

History

Apr 15, 2026 03:00 pm EDTSpecial Notice (Original)

RRPV Solicitation Summary: Rapid Antigen Production for Immunoassay Diagnostics (RAPID)

See also